All results
1 results
-
BabyCOVE: Moderna mRNA-1273-P206: A Phase 2, Two-Part Study (Open-Label [Part 1] Followed by Observer-Blind/Randomized [Part 2]) to Evaluate the Safety, Tolerability, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 Vaccine in Participants
This is a Phase 2, two-part, open-label in Part 1 and observer-blind, randomized, placebo controlled in Part 2 study to evaluate the safety, tolerability,…
- Ages
- 3 Years - 6 Years
- Sexes
- All